A study of octreotide in oesophageal varices.
A comparison of octreotide infusion (25 micrograms/h) and placebo in 16 stable cirrhotic patients revealed a 30% reduction in transhepatic venous gradient between 0 and 60 min in the octreotide group without an effect on systemic haemodynamics. In a separate trial, 40 patients with active variceal bleeding were randomized to octreotide infusion (25 micrograms/h for 48 h) or oesophageal tamponade. The 2 treatments gave comparable control of variceal bleeding. Tolerance of treatment was significantly better in the octreotide group. In summary, octreotide infusion is simple to administer, has few side effects, and may be of use in the immediate control of oesophageal bleeding.
McKee
R
R
Surgical Unit, Royal Infirmary, Glasgow, UK.
D004932:Esophageal and Gastric Varices / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D015282:Octreotide